Cleveland Clinic, Avita Health System partner on cancer care

The Cleveland Clinic Cancer Center and Avita Health System, a three-hospital system in Galion, Ohio, launched their affiliation March 6 to expand patients’ access to oncology and specialized treatment services.

Advertisement

Under the agreement, Cleveland Clinic cancer specialists will work with Avita clinicians to provide patients with direct access to care and collaborate on potential treatment options.

“Our research has shown that access, or getting cancer patients into treatment without delay, is associated with better outcomes,” said Brian Bolwell, MD, chairman of the Cleveland Clinic Taussig Cancer Institute. “This new affiliation with Avita will allow us to expand access to cancer services and specialized treatments for more cancer patients in Ohio.”

More articles on transactions and valuations:
State endorses Beth Israel Deaconess, Lahey Health proposed merger: 4 things to know
State OKs Southern New Hampshire Health, Elliot Hospital combination
UAB Health System signs second affiliation agreement in 4 weeks

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.